PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Implementation and Licence Agreement

1 Jun 2016 07:00

RNS Number : 8110Z
Arria NLG PLC
01 June 2016
 

1 June 2016

Arria NLG plc

("Arria NLG", or "Arria")

Implementation and Licence Agreement

 

Arria NLG plc (AIM: NLG), a leader in the development and deployment of Natural Language Generation ("NLG"), announces that it has successfully converted another initial proof of concept into two pilot applications which, on successful completion, will be deployed in the client's live environment for operational acceptance. The proof of concept was announced on 13 May 2015 with the UK arm of a global financial services group.

 

Under the new agreement, Arria will initially implement and deploy two applications into the chosen divisions of the client's UK business and parts of its international business for wider operational testing and user acceptance. Once accepted the applications are expected to be made available to the whole business for use in the client's live environment, where staff will access and use instances of the applications both on and off client premises. Configuration fees payable for this deployment stage will be followed by annual licensing fees upon final acceptance by the client.

Stuart Rogers, Chairman and Chief Executive of Arria NLG, stated: "We are very pleased to see our initial proof of concept project develop over 12 months into a pilot programme for our customer. Our technology will help aid our customer in its efficiency by delivering smarter, faster and improved outcomes from its existing business processes.

"We see the evolution from a proof of concept agreement to a pilot programme as an illustration of the value we can deliver through our leading natural language generation technologies."

 

For further information, please visit www.arria.com or contact:

Arria NLG plcStuart RogersChairman and Chief Executive

Tel +44 (0)20 7100 4540

Allenby Capital NominatedAdviser & Joint BrokerNick NaylorJeremy PorterJames Reeve

Tel: +44 (0)20 3328 5656

MSL Capital MarketsLead ManagerAndrew McDouallJustine DunnettPeter Lynds

Tel: +64 (0)4 472 2716

Stockdale SecuritiesJoint BrokerAntonio BossiRobert Finlay

Tel: +44 (0)20 7601 6100

IFC AdvisoryFinancial PR and IRTim MetcalfeGraham HerringHeather Armstrong

Tel: +44 (0)20 3053 8671

tim.metcalfe@investor-focus.co.uk graham.herring@investor-focus.co.uk heather.armstrong@investor-focus.co.uk

Ruder FinnPR (USA)Scott Beaver (West Coast)Brianna Mulligan (East Coast) 

Tel: +1 541-326-5847Tel: +1 203-246-1304

Arria NLG

Arria NLG's core product is known as the Arria NLG Platform, a form of artificial intelligence software specialised in extracting information from complex data sources and communicating that information in natural language (i.e. as if written by a human). The scientific foundation for the Arria NLG Platform is based on more than 30 years of research and development by the founders of Arria Data2Text Limited at the University of Aberdeen. For additional information, visit www.arria.com. Follow Arria NLG on Twitter, LinkedIn, Google+ and YouTube.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREAFSFDFLKEAF
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.